Cited by 266Alzheimer's disease research and treatmentsAutophagy in Disease and TherapyNeuroinflammation and Neurodegeneration Mechanisms

Enhancing Astrocytic Lysosome Biogenesis Facilitates Aβ Clearance and Attenuates Amyloid Plaque Pathogenesis

Open access
Xiao, Qingli, Yan, Ping, Ma, Xiucui, Liu, Haiyan, Perez, Ronaldo, Zhu, Alec, Gonzales, Ernesto, Burchett, Jack M. +4 more·2014·The Journal of Neuroscience

Abstract

In sporadic Alzheimer's disease (AD), impaired Aβ removal contributes to elevated extracellular Aβ levels that drive amyloid plaque pathogenesis. Extracellular proteolysis, export across the blood-brain barrier, and cellular uptake facilitate physiologic Aβ clearance. Astrocytes can take up and degrade Aβ, but it remains unclear whether this function is insufficient in AD or can be enhanced to accelerate Aβ removal. Additionally, age-related dysfunction of lysosomes, the major degradative organelles wherein Aβ localizes after uptake, has been implicated in amyloid plaque pathogenesis. We tested the hypothesis that enhancing lysosomal function in astrocytes with transcription factor EB (TFEB), a master regulator of lysosome biogenesis, would promote Aβ uptake and catabolism and attenuate plaque pathogenesis. Exogenous TFEB localized to the nucleus with transcriptional induction of lysosomal biogenesis and function in vitro. This resulted in significantly accelerated uptake of exogenously applied Aβ42, with increased localization to and degradation within lysosomes in C17.2 cells and primary astrocytes, indicating that TFEB is sufficient to coordinately enhance uptake, trafficking, and degradation of Aβ. Stereotactic injection of adeno-associated viral particles carrying TFEB driven by a glial fibrillary acidic protein promoter was used to achieve astrocyte-specific expression in the hippocampus of APP/PS1 transgenic mice. Exogenous TFEB localized to astrocyte nuclei and enhanced lysosome function, resulting in reduced Aβ levels and shortened half-life in the brain interstitial fluid and reduced amyloid plaque load in the hippocampus compared with control virus-injected mice. Therefore, activation of TFEB in astrocytes is an effective strategy to restore adequate Aβ removal and counter amyloid plaque pathogenesis in AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.3788-13.2014

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 50

  1. Avrahami L, Farfara D, Shaham-Kol M, Vassar R, Frenkel D, Eldar- Finkelman H (2013) Inhibition of glycogen synthase kinase-3 amelio- rates beta-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies. J Biol Chem 288:1295-1306. CrossRef Medline · DOI
  2. Baldo G, Wu S, Howe RA, Ramamoothy M, Knutsen RH, Fang J, Mecham RP, Liu Y, Wu X, Atkinson JP, Ponder KP (2011) Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation. Mol Genet Metab 104:608 -619. CrossRef Medline · DOI
  3. Barres BA (2008) The mystery and magic of glia: a perspective on their roles in health and disease. Neuron 60:430 -440. CrossRef Medline · DOI · Paper page
  4. Basak JM, Verghese PB, Yoon H, Kim J, Holtzman DM (2012) Low-density lipoprotein receptor represents an apolipoprotein E-independent path- way of Abeta uptake and degradation by astrocytes. J Biol Chem 287: 13959 -13971. CrossRef Medline · DOI · Paper page
  5. Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM (2006) Human amyloid-beta synthesis and clearance rates as measured in CSF in vivo. Nat Med 12:856 -861. CrossRef Medline · DOI · Paper page
  6. Butler D, Hwang J, Estick C, Nishiyama A, Kumar SS, Baveghems C, Young- Oxendine HB, Wisniewski ML, Charalambides A, Bahr BA (2011) Pro- tective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models. PLoS One 6:e20501. CrossRef Medline · DOI
  7. Cai Z, Zhao B, Li K, Zhang L, Li C, Quazi SH, Tan Y (2012) Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease? J Neurosci Res 90:1105-1118. CrossRef Medline · DOI
  8. Castellano JM, Deane R, Gottesdiener AJ, Verghese PB, Stewart FR, West T, Paoletti AC, Kasper TR, DeMattos RB, Zlokovic BV, Holtzman DM (2012) Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Abeta clearance in a mouse model of beta- amyloidosis. Proc Natl Acad Sci U S A 109:15502-15507. CrossRef Medline · DOI · Paper page
  9. Coen K, Flannagan RS, Baron S, Carraro-Lacroix LR, Wang D, Vermeire W, Michiels C, Munck S, Baert V, Sugita S, Wuytack F, Hiesinger PR, Grin- stein S, Annaert W (2012) Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN- deficient cells. J Cell Biol 198:23-35. CrossRef Medline · DOI · Paper page
  10. Cuervo AM, Dice JF (2000) When lysosomes get old. Exp Gerontol 35:119 - 131. CrossRef Medline · DOI
  11. Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Bjo ¨rklund A (2013) TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc Natl Acad Sci U S A 110:E1817- E1826. CrossRef Medline · DOI · Paper page
  12. Di Malta C, Fryer JD, Settembre C, Ballabio A (2012) Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder. Proc Natl Acad Sci U S A 109:E2334 -E2342. CrossRef Medline · DOI
  13. Fan TC, Chang HT, Chen IW, Wang HY, Chang MD (2007) A heparan sulfate-facilitated and raft-dependent macropinocytosis of eosinophil cationic protein. Traffic 8:1778 -1795. CrossRef Medline · DOI
  14. Hartmann T, Bieger SC, Bru ¨hl B, Tienari PJ, Ida N, Allsop D, Roberts GW, Masters CL, Dotti CG, Unsicker K, Beyreuther K (1997) Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat Med 3:1016 -1020. CrossRef Medline · DOI
  15. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R (2003) APP processing and synaptic function. Neuron 37:925-937. CrossRef Medline · DOI · Paper page
  16. Kanekiyo T, Zhang J, Liu Q, Liu CC, Zhang L, Bu G (2011) Heparan sul- phate proteoglycan and the low-density lipoprotein receptor-related pro- tein 1 constitute major pathways for neuronal amyloid-beta uptake. J Neurosci 31:1644 -1651. CrossRef Medline · DOI · Paper page
  17. Kato Y, Maruyama W, Naoi M, Hashizume Y, Osawa T (1998) Immunohis- tochemical detection of dityrosine in lipofuscin pigments in the aged human brain. FEBS Lett 439:231-234. CrossRef Medline · DOI
  18. Lafay-Chebassier C, Paccalin M, Page G, Barc-Pain S, Perault-Pochat MC, Gil R, Pradier L, Hugon J (2005) mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J Neurochem 94:215-225. CrossRef Medline · DOI · Paper page
  19. Lee JH, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, Uchiyama Y, Westaway D, Cuervo AM, Nixon RA (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 muta- tions. Cell 141:1146 -1158. CrossRef Medline · DOI · Paper page
  20. Lomakin A, Teplow DB, Kirschner DA, Benedek GB (1997) Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci U S A 94: 7942-7947. CrossRef Medline · DOI · Paper page
  21. Ma X, Liu H, Foyil SR, Godar RJ, Weinheimer CJ, Hill JA, Diwan A (2012) Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 125:3170 -3181. CrossRef Medline · DOI
  22. Macauley SL, Pekny M, Sands MS (2011) The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosis. J Neurosci 31: 15575-15585. CrossRef Medline · DOI · Paper page
  23. Mandrekar S, Jiang Q, Lee CY, Koenigsknecht-Talboo J, Holtzman DM, Lan- dreth GE (2009) Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis. J Neurosci 29:4252-4262. CrossRef Medline · DOI · Paper page
  24. Martina JA, Puertollano R (2013) Rag GTPases mediate amino acid- dependent recruitment of TFEB and MITF to lysosomes. J Cell Biol 200: 475-491. CrossRef Medline · DOI
  25. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ (2010) Decreased clearance of CNS beta- amyloid in Alzheimer's disease. Science 330:1774. CrossRef Medline · DOI · Paper page
  26. Medina DL, Fraldi A, Bouche V, Annunziata F, Mansueto G, Spampanato C, Puri C, Pignata A, Martina JA, Sardiello M, Palmieri M, Polishchuk R, Puertollano R, Ballabio A (2011) Transcriptional activation of lyso- somal exocytosis promotes cellular clearance. Dev Cell 21:421-430. CrossRef Medline · DOI
  27. Mousavi SA, Kjeken R, Berg TO, Seglen PO, Berg T, Brech A (2001) Effects of inhibitors of the vacuolar proton pump on hepatic heterophagy and autophagy. Biochim Biophys Acta 1510:243-257. CrossRef Medline · DOI
  28. Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, Wang X, Yu G, Esposito L, Mucke L, Gan L (2006) Antiamyloidogenic and neuro- protective functions of cathepsin B: implications for Alzheimer's disease. Neuron 51:703-714. CrossRef Medline · DOI
  29. Nagele RG, D'Andrea MR, Lee H, Venkataraman V, Wang HY (2003) As- trocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res 971:197-209. CrossRef Medline · DOI · Paper page
  30. Nielsen HM, Veerhuis R, Holmqvist B, Janciauskiene S (2009) Binding and uptake of A beta1-42 by primary human astrocytes in vitro. Glia 57:978 - 988. CrossRef Medline · DOI · Paper page
  31. Owen JB, Di Domenico F, Sultana R, Perluigi M, Cini C, Pierce WM, Butterfield DA (2009) Proteomics-determined differences in the concanavalin-A- fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: impli- cations for progression of AD. J Proteome Res 8:471-482. CrossRef Medline · DOI
  32. Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, Sardiello M, Ballabio A (2011) Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet 20:3852-3866. CrossRef Medline · DOI · Paper page
  33. Pen ˜a-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC, Wolff NC, Tran TA, Zou L, Xie XJ, Corey DR, Brugarolas J (2011) Regulation of TFEB and V-ATPases by mTORC1. EMBO J 30:3242-3258. CrossRef Medline · DOI
  34. Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B, Walther TC, Ferguson SM (2012) The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal 5:ra42. CrossRef Medline · DOI
  35. Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, Di Malta C, Donaudy F, Embrione V, Polishchuk RS, Banfi S, Parenti G, Cattaneo E, Ballabio A (2009) A gene network regulating lysosomal bio- genesis and function. Science 325:473-477. CrossRef Medline · DOI · Paper page
  36. Schipper HM, Bennett DA, Liberman A, Bienias JL, Schneider JA, Kelly J, Arvanitakis Z (2006) Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging 27:252-261. CrossRef Medline · DOI
  37. Schuur M, Ikram MA, van Swieten JC, Isaacs A, Vergeer-Drop JM, Hofman A, Oostra BA, Breteler MM, van Duijn CM (2011) Cathepsin D gene and the risk of Alzheimer's disease: a population-based study and meta- analysis. Neurobiol Aging 32:1607-1614. CrossRef Medline · DOI
  38. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, Facchinetti V, Sabatini DM, Ballabio A (2012) A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 31:1095-1108. CrossRef Medline · DOI
  39. Settembre C, Fraldi A, Medina DL, Ballabio A (2013a) Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat Rev Mol Cell Biol 14:283-296. CrossRef Medline · DOI
  40. Settembre C, De Cegli R, Mansueto G, Saha PK, Vetrini F, Visvikis O, Huynh T, Carissimo A, Palmer D, Klisch TJ, Wollenberg AC, Di Bernardo D, Chan L, Irazoqui JE, Ballabio A (2013b) TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat Cell Biol 15:647-658. CrossRef Medline · DOI · Paper page
  41. Song W, Wang F, Lotfi P, Sardiello M, Segatori L (2014) 2-Hydroxypropyl- beta-cyclodextrin promotes transcription factor EB-mediated activation of autophagy: implications for therapy. J Biol Chem 289:10211-10222. CrossRef Medline · DOI
  42. Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, Roque RA, Lazarowski ER, Damian VA, Masliah E, La Spada AR (2012) PGC-1alpha rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med 4:142ra97. CrossRef Medline · DOI
  43. Verges DK, Restivo JL, Goebel WD, Holtzman DM, Cirrito JR (2011) Op- posing synaptic regulation of amyloid-beta metabolism by NMDA recep- tors in vivo. J Neurosci 31:11328 -11337. CrossRef Medline · DOI · Paper page
  44. Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, Bu G, Frieden C, Holtzman DM (2013) ApoE influences amyloid-beta (Abeta) clear- ance despite minimal apoE/Abeta association in physiological conditions. Proc Natl Acad Sci U S A 110:E1807-1816. CrossRef Medline · DOI · Paper page
  45. Wolfe DM, Lee JH, Kumar A, Lee S, Orenstein SJ, Nixon RA (2013) Au- tophagy failure in Alzheimer's disease and the role of defective lysosomal acidification. Eur J Neurosci 37:1949 -1961. CrossRef Medline · DOI
  46. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, Silverstein SC, Husemann J (2003) Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9:453-457. CrossRef Medline · DOI · Paper page
  47. Xiao Q, Gil SC, Yan P, Wang Y, Han S, Gonzales E, Perez R, Cirrito JR, Lee JM (2012) Role of phosphatidylinositol clathrin assembly lymphoid- myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis. J Biol Chem 287: 21279 -21289. CrossRef Medline · DOI · Paper page
  48. Yan P, Bero AW, Cirrito JR, Xiao Q, Hu X, Wang Y, Gonzales E, Holtzman DM, Lee JM (2009) Characterizing the appearance and growth of amy- loid plaques in APP/PS1 mice. J Neurosci 29:10706 -10714. CrossRef Medline · DOI · Paper page
  49. Yang DS, Stavrides P, Mohan PS, Kaushik S, Kumar A, Ohno M, Schmidt SD, Wesson D, Bandyopadhyay U, Jiang Y, Pawlik M, Peterhoff CM, Yang AJ, Wilson DA, St George-Hyslop P, Westaway D, Mathews PM, Levy E, Cuervo AM, Nixon RA (2011) Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pa- thologies and memory deficits. Brain 134:258 -277. CrossRef Medline · DOI · Paper page
  50. Zang Y, Yu LF, Pang T, Fang LP, Feng X, Wen TQ, Nan FJ, Feng LY, Li J (2008) AICAR induces astroglial differentiation of neural stem cells via activating the JAK/STAT3 pathway independently of AMP-activated pro- tein kinase. J Biol Chem 283:6201-6208. CrossRef Medline · DOI

Cited by

Sorted by citations

Authors
Xiao, Q., Yan, P., Ma, X., Liu, H., Perez, R., Zhu, A., Gonzales, E., Burchett, J. M., Schuler, D. R., Cirrito, J. R., Diwan, A., & Lee, J.-M.
Affiliations
  • Hope Center for Neurological Disorders (US)
  • Washington University in St. Louis (US)
Venue
The Journal of Neuroscience
Published
2014-07-16
Volume
34
Issue
29
Pages
9607-9620
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2015662447
Cited by
266
References
18
Citations by year
2026: 16 · 2025: 23 · 2024: 21 · 2023: 17 · 2022: 23 · 2021: 36 · 2020: 26 · 2019: 21 · 2018: 25 · 2017: 17 · 2016: 21 · 2015: 17 · 2014: 3
FWCI
12.89
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
Funders
  • Alzheimer's Association (NIRG-12-242588)
  • BrightFocus Foundation (A2012151)
  • National Institutes of Health
  • National Institute on Aging (R01AG042513)
  • National Heart, Lung, and Blood Institute (R01HL107594)
  • National Institute of Neurological Disorders and Stroke (R21NS082529)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, amyloid-beta clearance, astrocytes, lysosomal biogenesis, TFEB, amyloid plaques, amyloid-beta 42, APP/PS1 mice, glial fibrillary acidic protein promoter, adeno-associated virus vectors, hippocampus, lysosomal dysfunction
MeSH terms
Animals, Animals, Newborn, Astrocytes, Cerebral Cortex, Disease Models, Animal, Female, Humans, Lysosomes, Male, Mice, Transgenic, Peptide Fragments, Transfection, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Mice, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Presenilin-1, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review